Notably, the proliferation-promotion effects of TAMs-CM-treated HSPCs on cancer cells were significantly inhibited following XIAOPI administration, and were subsequently reversed by CXCL1 overexpression (Fig. 3a). This evidence concerns the gene CXCL1 and cancer.